Effectiveness of Hepatitis C Drugs Praised; Cost a Concern

Doctors who treat hepatitis C are hailing the development of drugs that can effectively eradicate the infection, which is a leading cause of cirrhosis and liver cancer worldwide.  At the same time, their focus now has turned to reducing the high cost of treatment so that it’s accessible to developing countries, where 80 percent of people are infected. An estimated 150 to 185 million people worldwide are infected with hepatitis C and many don’t know it.  That’s because the virus...

© La Voix de l'Amérique - jeudi 10 avril 2014